Table 2.
Subjects | Model | Regulatory Mechanism | Functional Consequences | Reference |
---|---|---|---|---|
Betaine | Hep 2 cells, db/db mice | Decreased the production of IL-1β via interactions with FOXO1 and TXNIP and inhibited the activation of the NLRP3 inflammasome | Inhibition of RS-induced activation of the NLRP3 inflammasome in diabetic livers | [96] |
Mangiferin | Perivascular adipose tissue | Increased LKB1-dependent AMPK activity; inhibited NLRP3 inflammasome activation; reduced the secretion of IL-1β | Prevention of endothelial insulin resistance | [97] |
Berberine | ob/ob mice | Activation of AMPK-dependent autophagy in adipose tissue-resident macrophages | Alleviation of insulin resistance | [98] |
MUFA | Mice; Bone marrow-derived cells | Decreased the formation of pro-IL-1β, reduced the secretion of IL-1β and maintained the activation of adipose AMPK | Improved insulin resistance mediated by IL-1β and adipose dysfunction | [99] |
SFA | Mice; BMDC; | Improved the expression of IL-1R1, TLR4, and caspase-1 and increased the secretion of IL-1β | Decreased insulin levels in adipose | [89] |
WMW | HepG2 cells | Regulated the downstream insulin signaling pathway via reduced IR and IRS-1; decreased IL-1β and NFκB | Alleviation of insulin resistance | [100] |
CBX | Mice | Suppressed the IκB-α/NF-κB pathway and inhibited the activation of the NLRP3 inflammasome | Alleviation of insulin resistance in the liver and skeletal muscle | [101] |
Silymarin | Hnf-1α- knockout mice | Reduced expression of IL-1β mediated by HG and inflammasome | Alleviation of insulin resistance | [102] |
RS: reactive species; MUFA: Monounsaturated Fatty Acid; SFA: saturated fatty acids; BMDC: bone marrow-derived dendritic cells; WMW: Wu-Mei-Wan, a Chinese herbal formula; IR: insulin receptor; IRS-1: insulin receptor substrate-1; CBX: Carbenoxolone; HG: high glucose.